Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol.

Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol. Abstract Text:

    j balcellsJ Balcells,m rodríguezM Rodríguez,m pujolM Pujol,j iglesiasJ Iglesias,

    Esmolol is a cardioselective beta-blocker with very rapid onset of action and short half-life due to its metabolism by blood-borne esterases. This unique profile among currently available beta-blockers renders esmolol highly useful in critical care situations. However, published experience with the use of esmolol in critically ill children is scant. The case of a 4-year-old boy with secondary long QT syndrome and ventricular tachycardia successfully treated with esmolol is presented.

    Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol. Publishing Authors By Initials

    j balcellsJ Balcells,m rodríguezM Rodríguez,m pujolM Pujol,j iglesiasJ Iglesias,

    For similar cardiovascular diseases: heart diseases: arrhythmias, cardiac: tachycardia: tachycardia, ventricular research abstracts see: cardiovascular diseases: heart diseases: arrhythmias, cardiac: tachycardia: tachycardia, ventricular research

    PUBMED ID PMID:

    MEDLINE DATE: 2004 Mar-Apr

    Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Pediatric cardiology

    VOLUME: 25

    Page Numbers: 160-2

    Journal Abbreviation: Pediatr Cardiol

    ISSN: 0172-0643

    DAY: 20

    MONTH: 02

    YEAR: 2008

    Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8003849

    Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol. Keywords Mesh Terms:

    KEYWORDS: Tachycardia, Ventricular

    MESH TERMS: etiology

    Chemical & Substance for Abstract: Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol. Information

    Substance Name: esmolol

    Registry Number: 84057-94-3

    Grant and Affiliation Information for Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol.

    AFFILIATION: Pediatric Intensive Care Unit, Hospital Vall d'Hebron, Barcelona, Spain. jbalcell@cs.vhebron.es

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Pediatr Cardiol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News